Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
164 participants
INTERVENTIONAL
2017-01-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
L-carnitine and Metformin in Obese PCOS Women.
NCT03108963
Adding L-carnitine in Clomiphene Resistant Polycystic Ovary Improves the Quality of Ovulation and the Pregnancy Outcome
NCT01665547
The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients
NCT06836128
NAC in CC Resistant PCOS After LOD
NCT02775734
N-acetyl Cysteine and Clomiphene Citrate or Metformin and Clomiphene Citrate for Women With CC Resistant Polycystic Ovary Syndrome (PCOS).
NCT01008046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
N-Acetylcysteine
N-Acetylcysteine used by clomiphene resistant pcos women
N-Acetylcysteine
N-Acetylcysteine in clomiphene resistant pcos women
L-carnitine
L-carnitine used by clomiphene resistant pcos women
L-carnitine
L-carnitine in clomiphene resistant pcos women
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
N-Acetylcysteine
N-Acetylcysteine in clomiphene resistant pcos women
L-carnitine
L-carnitine in clomiphene resistant pcos women
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* infertile
Exclusion Criteria
* no hormonal treatment in the previous 3 months
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zagazig University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
IBRAHIM ABD ELGAFOR
assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ibrahim A EL sharkwy, MD
Role: PRINCIPAL_INVESTIGATOR
FACULTY OF MEDICINE ,ZAGAZIG UNIVERSITY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zagazig University
Zagazig, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
El Sharkwy IA, Abd El Aziz WM. Randomized controlled trial of N-acetylcysteine versus l-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome. Int J Gynaecol Obstet. 2019 Oct;147(1):59-64. doi: 10.1002/ijgo.12902. Epub 2019 Jul 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZUH 7
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.